All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
| TLGT / Teligent Inc
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| AVRO / AVROBIO, Inc.
|
|
|
|
|
|
|
|
| MDCO / Medicines Company
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| / Immunomedics, Inc.
|
|
|
|
|
|
|
|
| 71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
|
|
|
|
|
|
|
|
| ACER / Acer Therapeutics Inc
|
|
|
|
|
|
|
|
| PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
| TCDA / Tricida Inc
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
|
|
|
|
|
|
|
|
| ONCS / OncoSec Medical Inc
|
|
|
|
|
|
|
|
| ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| SPPI / Spectrum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALIM / Alimera Sciences, Inc.
|
|
|
|
|
|
|
|
| SESN / Sesen Bio Inc.
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FENC / Fennec Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
| ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
